Aradigm Corp (ARDM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
32
About the Report
About the Report
Summary
Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The company's product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic bronchiectasis (BE) and cystic fibrosis (CF); ARD-1100, liposomal ciprofloxacin for the treatment of inhalation tularemia, anthrax infections, Q fever and pneumonic plague and ARD-1600, for the prevention and treatment of respiratory and other diseases in tobacco smokers through smoking cessation. Its proprietary pulmonary drug delivery platform, AERx, is customized for the delivery of drugs to the target along with liposomal formulations. Aradigm is headquartered in Hayward, California, the US.
Aradigm Corp (ARDM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Aradigm Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aradigm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Aradigm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Aradigm Corp, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Grifols Enters Into Licensing Agreement With Aradigm 11
Ingeniatrics Enters Into Licensing Agreement With Aradigm For Flow Focusing And Flow Blurring Technology 13
Equity Offering 14
Aradigm Rasies USD6 Million in Private Placement Of Shares 14
Aradigm Files Registration Statement for Public offering of Shares for up to USD20 Million 15
Debt Offering 16
Aradigm Raises Funds through First Tranche Private Placement of 9% Notes Due 2021 16
Acquisition 17
Grifols Completes Acquisition Of 35% Stake In Aradigm For USD 26 Million 17
Aradigm Corp-Key Competitors 18
Aradigm Corp-Key Employees 19
Aradigm Corp-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 14, 2018: Aradigm announces second quarter 2018 financial results 21
May 15, 2018: Aradigm Reports First Quarter 2018 Financial Results 22
Mar 23, 2018: Aradigm Reports Fourth Quarter 2017 And Full Year Financial Results 23
Nov 02, 2017: Aradigm Announces Third Quarter 2017 Financial Results 25
Aug 10, 2017: Aradigm Announces Second Quarter 2017 Financial Results 26
May 15, 2017: Aradigm Announces First Quarter 2017 Financial Results 27
Mar 28, 2017: Aradigm Announces Fourth Quarter 2016 and Full Year Financial Results 28
Corporate Communications 29
Jul 06, 2018: Aradigm Names Dr. Theresa Matkovits As Board Director 29
Feb 09, 2018: Aradigm Announces Personnel Changes 30
Oct 10, 2017: Aradigm Regains Compliance with NASDAQ Listing Requirements 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Figure
List of Figures
Aradigm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aradigm Corp, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Aradigm Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aradigm Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aradigm Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aradigm Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Aradigm Corp, Medical Devices Deals, 2012 to YTD 2018 9
Aradigm Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Grifols Enters Into Licensing Agreement With Aradigm 11
Ingeniatrics Enters Into Licensing Agreement With Aradigm For Flow Focusing And Flow Blurring Technology 13
Aradigm Rasies USD6 Million in Private Placement Of Shares 14
Aradigm Files Registration Statement for Public offering of Shares for up to USD20 Million 15
Aradigm Raises Funds through First Tranche Private Placement of 9% Notes Due 2021 16
Grifols Completes Acquisition Of 35% Stake In Aradigm For USD 26 Million 17
Aradigm Corp, Key Competitors 18
Aradigm Corp, Key Employees 19
Aradigm Corp, Subsidiaries 20
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.